Literature DB >> 16628572

Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to Noroviruses.

GwangPyo Ko1, Zhi-Dong Jiang, Pablo C Okhuysen, Herbert L DuPont.   

Abstract

The intestinal immune and inflammatory responses of Norovirus (NoV) are poorly defined. The objective of this study was to investigate fecal cytokine and lactoferrin profiles in response to NoV gastroenteritis in travelers. Both fecal cytokines and fecal lactoferrin were measured for NoV-associated diarrhea (N = 7), mixed infection of NoV and enterotoxigenic E. coli (ETEC)-associated diarrhea (N = 10) and in pathogen-negative diarrhea cases (N = 19). Both IL-2 and IFN-gamma were significantly increased in NoV-associated diarrhea specimens, suggesting a predominant Th1 immune response to NoV infection in the gut. When a mixed infection of NoV and ETEC occurred, a combined Th1/Th2 response was observed suggesting a dual immune response secondary to infection by both pathogens. Intestinal inflammation associated with increased fecal lactoferrin, important in bacterial enteric infection, was not found in NoV-associated gastroenteritis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628572     DOI: 10.1002/jmv.20630

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  15 in total

1.  Lack of effect of murine norovirus infection on a mouse model of bacteria-induced colon cancer.

Authors:  Karen C Lencioni; Rolf Drivdahl; Audrey Seamons; Piper M Treuting; Thea Brabb; Lillian Maggio-Price
Journal:  Comp Med       Date:  2011-06       Impact factor: 0.982

2.  Transient or persistent norovirus infection does not alter the pathology of Salmonella typhimurium induced intestinal inflammation and fibrosis in mice.

Authors:  Peter D R Higgins; Laura A Johnson; Kay Sauder; David Moons; Luz Blanco; Stefan Taube; Christiane E Wobus
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2011-01-14       Impact factor: 2.268

3.  Seroepidemiology of norovirus-associated travelers' diarrhea.

Authors:  Nadim J Ajami; Owen V Kavanagh; Sasirekha Ramani; Sue E Crawford; Robert L Atmar; Zhi-Dong Jiang; Pablo C Okhuysen; Mary K Estes; Herbert L DuPont
Journal:  J Travel Med       Date:  2014 Jan-Feb       Impact factor: 8.490

4.  Vitamin A modifies the intestinal chemokine and cytokine responses to norovirus infection in Mexican children.

Authors:  Kurt Z Long; Coralith Garcia; GwangPyo Ko; Jose I Santos; Abdullah Al Mamun; Jorge L Rosado; Herbert L DuPont; Nanda Nathakumar
Journal:  J Nutr       Date:  2011-03-16       Impact factor: 4.798

5.  New perspectives regarding the antiviral effect of vitamin A on norovirus using modulation of gut microbiota.

Authors:  Heetae Lee; GwangPyo Ko
Journal:  Gut Microbes       Date:  2017-08-03

Review 6.  Norovirus immunology: Of mice and mechanisms.

Authors:  Kira L Newman; Juan S Leon
Journal:  Eur J Immunol       Date:  2015-08-25       Impact factor: 5.532

7.  Usefulness of fecal lactoferrin and hemoglobin in diagnosis of colorectal diseases.

Authors:  Ichiro Hirata; Masahiro Hoshimoto; Osamu Saito; Masanobu Kayazawa; Takashi Nishikawa; Mitsuyuki Murano; Ken Toshina; Fang-Yu Wang; Ryoichi Matsuse
Journal:  World J Gastroenterol       Date:  2007-03-14       Impact factor: 5.742

8.  Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico.

Authors:  Jose Flores; Herbert L DuPont; Stephanie A Lee; Jaime Belkind-Gerson; Mercedes Paredes; Jamal A Mohamed; Lisa Y Armitige; Dong-Chuan Guo; Pablo C Okhuysen
Journal:  Clin Vaccine Immunol       Date:  2008-06-25

9.  Study of the diagnostic value of interleukin-6 and interleukin-8 in children with acute gastroenteritis.

Authors:  Maysaa El Sayed Zaki; Mona Abdel Latif Alsayed; Raghdaa Shrief
Journal:  Germs       Date:  2020-03-02

Review 10.  Norovirus encounters in the gut: multifaceted interactions and disease outcomes.

Authors:  Ebrahim Hassan; Megan T Baldridge
Journal:  Mucosal Immunol       Date:  2019-09-09       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.